SMAD3 and pulmonary arterial hypertension: For instance, it was confirmed that a prostacyclin analog called treprostinil can inhibit the TGF-β pathway by suppressing Smad3 phosphorylation in MCT-induced PAH rats with increased TGF-β signaling [81].